loadpatents
name:-0.019556999206543
name:-0.011183977127075
name:-0.001410961151123
Mizuguchi; Hiroyuki Patent Filings

Mizuguchi; Hiroyuki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mizuguchi; Hiroyuki.The latest application filed is for "medicinal composition for treating fibrosis".

Company Profile
1.11.15
  • Mizuguchi; Hiroyuki - Suita JP
  • Mizuguchi; Hiroyuki - Osaka JP
  • Mizuguchi; Hiroyuki - Suita-shi Osaka
  • Mizuguchi; Hiroyuki - Ibaraki JP
  • MIZUGUCHI; Hiroyuki - Ibaraki-shi JP
  • Mizuguchi; Hiroyuki - Minoo JP
  • Mizuguchi; Hiroyuki - Minoo-shi JP
  • Mizuguchi; Hiroyuki - Mino-shi JP
  • Mizuguchi; Hiroyuki - Tokyo JP
  • Mizuguchi; Hiroyuki - Shizuoka JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Medicinal composition for treating fibrosis
Grant 11,077,157 - Sakurai , et al. August 3, 2
2021-08-03
Intestinal epithelioid cells
Grant 10,889,805 - Mizuguchi , et al. January 12, 2
2021-01-12
Medicinal Composition for Treating Fibrosis
App 20190151384 - Sakurai; Fuminori ;   et al.
2019-05-23
Intestinal Epithelioid Cells
App 20180320144 - Mizuguchi; Hiroyuki ;   et al.
2018-11-08
Conditionally replicating adenovirus
Grant 9,624,476 - Mizuguchi , et al. April 18, 2
2017-04-18
Method Of Differentiation From Stem Cells To Hepatocytes
App 20170009203 - Mizuguchi; Hiroyuki ;   et al.
2017-01-12
Adenovirus vector
Grant 9,540,658 - Mizuguchi , et al. January 10, 2
2017-01-10
Conditionally Replicating Adenovirus
App 20160333323 - MIZUGUCHI; Hiroyuki ;   et al.
2016-11-17
Method For Culturing Hepatoblast-Like Cells And Culture Product Thereof
App 20160046904 - MIZUGUCHI; Hiroyuki ;   et al.
2016-02-18
Conditionallly Replication-competent Adenovirus
App 20140199688 - Mizuguchi; Hiroyuki ;   et al.
2014-07-17
Method Of Differentiation From Stem Cells To Hepatocytes
App 20120231490 - Mizuguchi; Hiroyuki ;   et al.
2012-09-13
Telomelysin/GFP-expressing recombinant virus
Grant 7,943,373 - Fujiwara , et al. May 17, 2
2011-05-17
Telomelysin/GFP-expressing recombinant virus
App 20110111480 - FUJIWARA; TOSHIYOSHI ;   et al.
2011-05-12
Telomelysin/gfp-expressing Recombinant Virus
App 20080032283 - Fujiwara; Toshiyoshi ;   et al.
2008-02-07
Novel virus vector
App 20060258005 - Mayumi; Tadanori ;   et al.
2006-11-16
Adenoviral vector and methods for making and using the same
Grant 7,045,344 - Kay , et al. May 16, 2
2006-05-16
Telomelysin/GFP-expressing recombinant virus
App 20060067890 - Fujiwara; Toshiyoshi ;   et al.
2006-03-30
Adenovirus vector
App 20050176129 - Mizuguchi, Hiroyuki ;   et al.
2005-08-11
Adenovirus vector
Grant 6,921,663 - Mizuguchi , et al. July 26, 2
2005-07-26
Novel adenoviral vector and methods for making and using the same
App 20040106193 - Kay, Mark A. ;   et al.
2004-06-03
Adenovirus vector
App 20020058045 - Mizuguchi, Hiroyuki ;   et al.
2002-05-16
Adenoviral vector and methods for making and using the same
Grant 6,303,362 - Kay , et al. October 16, 2
2001-10-16
Immobilization of biological material with an acrylonitrile polymer
Grant 4,371,612 - Matsumoto , et al. February 1, 1
1983-02-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed